Session » Antiphospholipid Syndrome Poster
-
Abstract Number: 156
Assessing the Role of Ascvd Score in Primary Thrombosis Prophylaxis Strategy Among Asymptomatic Antiphospholipid Antibody Carriers
-
Abstract Number: 157
Identifying Additional Risk Factors Associated with Thrombosis and Pregnancy Morbidity in a Unique Cohort of Antiphospholipid Antibody Positive Chinese Patients
-
Abstract Number: 158
Incidence and Prevalence of Antiphospholipid Syndrome in a Health Management Organization (HMO): A 15-Year Study
-
Abstract Number: 159
The Frequency of Screening and Prevalence of Antiphospholipid Antibodies in the General Population
-
Abstract Number: 162
Mammalian Target of Rapamycin (mTOR) Pathway Assessment in Antiphospholipid Antibody Positive Patients with Livedo Reticularis/racemosa
-
Abstract Number: 163
Development of New International Classification Criteria for Antiphospholipid Syndrome: Phase II Item Reduction Survey
-
Abstract Number: 164
Reliability of Lupus Anticoagulant and Anti-Phosphatidylserine/Prothrombin Autoantibodies in Antiphosphospholipid Syndrome: A Multicenter Study
-
Abstract Number: 165
Clinical and Immunological Features of Antiphospholipid Syndrome in the Elderly: A Retrospective National Multicenter Study
-
Abstract Number: 167
Recurrent Thrombosis in Patients with Antiphospholipid Antibodies Following an Initial Venous or Arterial Thromboembolic Event
-
Abstract Number: 168
IgG Anti-High-Density Lipoproteins Antibodies Discriminate between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
-
Abstract Number: 169
Prognosis of Patients with Antiphospholipid Syndrome Nephropathy
-
Abstract Number: 170
Predictive Value of Antiphospholipid Antibodies in the Acute Phase of Deep Vein Thrombosis
-
Abstract Number: 171
Flow Cytometric Assessment of the Mammalian Target of Rapamycin Pathway Using Antiphospholipid Syndrome As a Disease Model
-
Abstract Number: 172
Serum Chemokines and miRNA Levels and Its Association with Cumulative Organ Damage in Patients with Antiphospholipid Syndrome: A Bench to Bedside Study